Citigroup
CNTB

Citigroup’s Connect Biopharma Holdings CNTB Stock Holding History

Citigroup’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3 Buy
+1
New +$3 ﹤0.01% 5806
2025
Q4 		– Sell
-4,214
Closed -$6.24K – 6125
2025
Q3 		$6.24K Buy
+4,214
New +$7.46K ﹤0.01% 5173
2023
Q1 		– Sell
-139,196
Closed -$121K – 5553
2022
Q4 		$121K Sell
139,196
-75,517
-35% -$62.2K ﹤0.01% 3951
2022
Q3 		$277K Sell
214,713
-160,654
-43% -$193K ﹤0.01% 3606
2022
Q2 		$327K Buy
375,367
+374,314
+35,547% +$551K ﹤0.01% 3548
2022
Q1 		$3K Sell
1,053
-1,910
-64% -$8.06K ﹤0.01% 5949
2021
Q4 		$15K Buy
2,963
+1,965
+197% +$21.8K ﹤0.01% 5466
2021
Q3 		$24K Sell
998
-415
-29% -$9.39K ﹤0.01% 5150
2021
Q2 		$28K Buy
+1,413
New +$23.6K ﹤0.01% 5117

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Citigroup's CNTB Position: Q1 2026 in Review

Citigroup opened a new position in Connect Biopharma Holdings (CNTB) in Q1 2026: 1 share worth $3. The stake represents ﹤0.01% of the portfolio and ranks #5806 among its holdings. This is a return to the name: Citigroup previously reported a position in CNTB as recently as Q3 2025.

Citigroup first reported a position in CNTB in Q2 2021 and has held it in 9 quarters since. The position peaked at $327K in Q2 2022. 41 funds tracked by Wall St. Rank hold CNTB as of Q1 2026.

  • Citigroup held 1 share of Connect Biopharma Holdings worth $3 as of Q1 2026.
  • Connect Biopharma Holdings was a new Citigroup position in Q1 2026.
  • Connect Biopharma Holdings made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5806 holding.
  • Citigroup first reported a position in Connect Biopharma Holdings in Q2 2021 and has held it in 9 quarters since.
  • Citigroup's Connect Biopharma Holdings position peaked at $327K in Q2 2022.
  • 41 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.